行政院衛生福利部國民健康署。(2002) 高血壓、高血糖、高血脂調查。http://www.doh.gov.tw (2011年上網)
行政院衛生福利部國民健康署。(2007) 台灣地區對於代謝症候群之定義。 http://www.doh.gov.tw (2012年上網)
行政院衛生福利部國民健康署。(2013) 民國101年主要死因統計結果。http://www.mohw.gov.tw/MOHW_Upload/doc/ 資料於2013年9月10日下載。
行政院衛生福利部國民健康署。(2014) 102 年國人主要死因統計。http://www.mohw.gov.tw/cht/Ministry/DM2_P.aspx?f_list_no=7&fod_list_no=4558&doc_no=45347 (2014年上網)
行政院衛生福利部國民健康署。(2015) 103 年國人主要死因統計。http://www.hpa.gov.tw/Bhpnet/Web/Easy/FormCenterShow.aspx?No=201111030001 (2015年上網)
李時珍。(2000) 新訂本草綱目,世一文化事業股份有限公司。
周玲。(2006) 石花菜的藥用食療,四川烹飪烹高等專科學校學報。
林柏成。(2010) 台灣北部石花菜屬 (Gelidium spp.) 海藻採集的時空特性與永續經營研究,中國文化大學地學研究所碩士論文。侯松柏。(2007) 數種台灣可食用性藻類之抗氧化評估,國立台灣海洋大學食品科學研究所碩士論文。
孫乃云。(2006) 石花菜 (Gelidium) 水萃取液抗氧化及抗癌活性之探討,國立台灣海洋大學水產養殖系碩士論文。國立台灣博物館 <數位典藏與數位學習聯合目錄>。(1980) [中文名:安曼司石花菜 (A001257)]。http://catalog.digitalarchives.tw/item/00/04/85/c8.html (2015 年上網)。
黃淑芳。(2000) 臺灣東北角海藻圖錄,國立臺灣博物館。劉宣辰。(2011) 安曼司石花菜對高果糖飲食大鼠醣類與脂質代謝之影響,國立台灣海洋大學食品科學研究所碩士論文。薛希如。(2009)台灣產石花菜科 (石花菜目,紅藻植物門) 系統分類重新探討,國立台灣海洋大學海洋生物研究所碩士學位論文。簡毓辰。(2008) 石花菜對STZ 誘發之第2 型糖尿病大鼠醣類代謝與脂質代謝之影響,國立台灣海洋大學食品科學系碩士學位論文。蘇惠美。(2014) 水試所微藻種原之收集與利用,水產試驗所專訊。
Abidov M, Ramazanov Z, Seifulla R, Grachev S. 2010. The effects of Xanthigen™ in the weight management of obese premenopausal women with non‐alcoholic fatty liver disease and normal liver fat. Diabetes, obesity and metabolism, 12, 72-81.
Adiels M, Westerbacka J, Soro-Paavonen A, Häkkinen A M., Vehkavaara S, Caslake MJ, Borén J. 2007. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia, 50, 2356-2365.
Akiyama S, Katsumata SI, Suzuki K, Nakaya Y, Ishimi Y, Uehara M. 2009. Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in Goto-Kakizaki rats with type 2 diabetes. Bioscience biotechnology and biochemistry, 73, 2779-2782.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA. 2009. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; International atherosclerosis society; and international association for the study of obesity. Circulation, 120, 1640-1645.
Alberti KGMM, Zimmet PF. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic medicine, 15, 539-553.
Allouch J, Jam M, Helbert W, Barbeyron T, Kloareg B, Henrissat B, Czjzek M. 2003. The three-dimensional structures of two β-agarases. Journal of biological chemistry, 278, 47171-47180.
Alsaif MA, Duwaihy M. 2004. Influence of dietary fat quantity and composition on glucose tolerance and insulin sensitivity in rats. Nutrition research, 24, 417-425.
American diabetes association (ADA). 2012. Diagnosis and classification of diabetes mellitus. Diabetes care, 35, 64-71.
American Diabetes Association (ADA). 2014. Diagnosis and classification of diabetes mellitus. Diabetes care, 37, 81-90.
Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB. 2008. Cancer is a preventable disease that requires major lifestyle changes. Pharmaceutical research, 25, 2097-2116.
Andersen RA. 2005. Algal culturing techniques. Academic press.
Anderson JW, Kendall CW, Jenkins DJ. 2003. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. Journal of the american college of nutrition, 22, 331-339.
Andersson H. 1992. The ileostomy model for the study of carbohydrate digestion and carbohydrate effects on sterol excretion in man. European journal of clinical nutrition, 46, 69-76.
Ansquer JC, Foucher C. 2014. The PPAR system in diabetes. In: Lipoproteins in diabetes mellitus. New York. Springer, 357-372.
Antuna-Puentea B, Fevec B, Fellahi S, Bastard JP. 2008. Adipokines: The missing link between insulin resistance and obesity. Diabetes and metabolism, 34, 2-11.
Arakawa M, Masaki T, Nishimura J, Seike M, Yoshimatsu H. 2011. The effects of branched-chain amino acid granules on the accumulation of tissue triglycerides and uncoupling proteins in diet-induced obese mice. Endocrine journal, 58, 161-170.
Araki C. 1956. Structure of the agarose constituent of agar-agar. Bulletin of the chemical society of Japan, 29, 543-544.
Arbeeny CM, Meyers DS, Bergquist KE, Gregg RE. 1992. Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster. Journal of lipid research, 33, 843-851.
Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL. 2004. Neonatal streptozotocin-induced rat of type 2 diabetes mellitus: A glance. Indian Journal of pharmacology, 36, 217-221.
Association of Official Analytical Chemists (AOAC). 1984. Horwitz W, editor. Official Methods of Analysis. 13th edition. Washington, D.C., USA.
Association of Official Analytical Chemists (AOAC). 1984. Horwitz W, editor. Official Methods of Analysis. 14th edition. Washington, D.C., USA.
Association of Official Analytical Chemists (AOAC). 1996. Horwitz W, editor. Official Methods of Analysis. 16th edition. Washington, D.C., USA.
Atkinson LL, Kozak R, Kelly SE, Onay-Besikci A, Russell JC, Lopaschuk GD. 2003. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats. American journal of physiology-endocrinology and metabolism, 284, 923-930.
Aubin MC, Lajoie C, Clément R, Gosselin H, Calderone A, Perrault LP. 2008. Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: Therapeutic potential of resveratrol. Journal of pharmacology and experimental therapeutics, 325, 961-968.
Awang AN, Ng JL, Matanjun P, Sulaiman MR, Tan TS, Ooi, YBH. 2014. Anti-obesity property of the brown seaweed, Sargassum polycystum using an in vivo animal model. Journal of applied phycology, 26, 1043-1048.
Bartley GE, Yokoyama W, Young SA, Anderson WH, Hung SC, Albers DR, Langhorst ML, Kim H. 2010. Hypocholesterolemic effects of hydroxypropyl methylcellulose are mediated by altered gene expression in hepatic bile and cholesterol pathways of male hamsters. The journal of nutrition, 140, 1255-1260.
Bastard JP, Maachi M, Nhieu JTV, Jardel C, Bruckert E, Grimaldi A., Robert JJ, Capeau J, Hainque B. 2002. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. The Journal of clinical endocrinology and metabolism, 87, 2084-2089.
Berger JJ. Barnard RJ. 1999. Effect of diet on fat cell size and hormone-sensitive lipase activity. Journal of applied physiology, 87, 227-232.
Bessesen DH. 2001. The role of carbohydrates in insulin resistance. Journal of nutrition, 131, 2782-2786.
Bieger WP, Michel G, Barwich D, Biehl K, Wirth A. 1984. Dim-inished insulin receptors on monocytes and erythrocytes in hypertriglyceridemia. Metabolism, 33, 982-987.
Bloomgarden ZT. 2002. Adiposity and diabetes. Diabetes care, 25, 2342-2349.
Blundell JE, Naslund E. 1999. Glucagon-like peptide-1, satiety and appetite control. British journal of nutrition, 81, 259-260.
Boizard M, Le Liepvre X, Lemarchand P, Foufelle F, Ferré P, Dugail I. 1998. Obesity-related overexpression of fatty-acid synthase gene in adipose tissue involves sterol regulatory element-binding protein transcription factors. Journal of biological chemistry, 273, 29164-29171.
Boo GH, Park JK, Boo SM. 2013. Gelidiophycus (Rhodophyta: Gelidiales): a new genus of marine algae from East Asia. Taxon, 62, 1105-1116.
Brockman DA, Chen X, Gallahe, DD. 2014. High-viscosity dietary fibers reduce adiposity and decrease hepatic steatosis in rats fed a high-fat diet. The journal of nutrition, 144, 1415-1422.
Butt MS, Ahmad A, Sharif MK. 2007. Influence of pectin and guar gum composite flour on plasma biochemical profile of streptozotocin-induced diabetic male albino rats. International journal of food properties, 10, 345-361.
Callaway E. 2015. Lab staple agar runs low: dwindling seaweed harvest imperils reagent essential for culturing microbes. Nature, 528, 171-173.
Carlson SE, Goldford S. 1979. A sensitive enzymatic method of determination of free and esterified tissue cholesterol. Clinica chimica acta, 79, 575-582.
Catena C, Giacchetti G, Novello M, Colussi G, Cavarape A, Sechi LA. 2003. Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. American journal of hypertension, 16, 973-978.
Chandalia M, Garg A, Lutjohann D, Bergmann K, Grundy SM, Brinkley LJ. 2000. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. New England journal of medicine, 342, 1392-1398.
Chang CW, Hsu YJ, Chen YM, Huang WC., Huang CC, Hsu MC. 2015. Effects of combined extract of cocoa, coffee, green tea and garcinia on lipid profiles, glycaemic markers and inflammatory responses in hamsters. BMC complementary and alternative medicine, 15, 269-279.
Chang HP, Yao HT, Chiang MT. 2012. Effects of high and low molecular weight chitosan on plasma cholesterol, glucose and adipocytokines in diabetic rats induced by streptozotocin and nicotinamide. Journal of food and drug analysis, 20, 661-667.
Chao PY, Lin JA, Ting WJ, Lee HH, Hsieh K, Chiu YW, Huang CY. 2016. Ocimum gratissmum aqueous extract reduces plasma lipid in hypercholesterol-fed hamsters. International journal of medical sciences, 13, 819-824.
Chen YH, Tu CJ, Wu HT. 2004. Growth-inhibitory effects of the red alga gelidium amansii on cultured cells. Biological and pharmaceutical bulletin, 27, 180-184.
Cherng JY, Shih MF. 2005. Preventing dyslipidemia by chlorella yrenoidosa in rats and hamsters after chronic high fat diet treatment. Life sciences, 76, 3001-3013.
Chiu CY, Chan IL, Yang TH, Liu SH, Chiang MT. 2015. Supplementation of chitosan alleviates high-fat diet-enhanced lipogenesis in rats via adenosine monophosphate (AMP)-activated protein kinase activation and inhibition of lipogenesis-associated genes. Journal of agricultural and food chemistry, 63, 2979-2988.
Choi YS, Goto S, Ikeda I, Sugano M. 1989. Interaction of dietary protein, cholesterol and age on lipid metabolism of the rat. British journal of nutrition, 61, 531-543.
Chopra M, Galbraith S, Darnton-Hill I. 2002. A global response to a global problem: the epidemic of overnutrition. Bulletin of the world health organization, 80, 952-958.
Chu WL, Phang SM. 2016. Marine algae as a potential source for anti-obesity agents. Marine drugs, 14, 222-240.
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, StephensTW, Nyce MR. Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. England journal of medicine, 334, 292-295.
Cox S, Abu-Ghannam N, Gupta S. 2010. An assessment of the antioxidant and antimicrobial activity of six species of edible Irish seaweeds. International Food Research Journal, 17, 205-220.
Dayrit CS. 2003. Coconut oil: atherogenic or not (what therefore causes atherosclerosis). Philippine journal of cardiology, 31, 97-104.
Delzenne NM, Cani PD. 2005. A place for dietary fibre in the management of the metabolic syndrome. Current opinion in clinical nutrition and metabolic care, 8, 636-640.
den-Besten G, Gerding A, van Dijk TH, Ciapaite J, Bleeker A, van Eunen K, Havinga R, Groen AK, Reijngoud DJ, Bakker BM. 2015. Protection against the metabolic syndrome by guar gum-derived short-chain fatty acids depends on peroxisome proliferator-activated receptor γ and glucagon-like peptide-1. PloS one, 10, 1-14.
Dubois M. 1956. Colorimetric method for determination of sugars and related substances. Analytical Chemistry, 28, 350-356.
Duckworth M, Yaphe W. 1971. The structure of agar: Part I. fractionation of a complex mixture of polysaccharides. Carbohydrate research, 16, 189-197.
Dunn JS, Kirkpatrick J, McLetchie NGB, Telfer SV. 1943. Necrosis of the islets of Langerhans produced experimentally. The journal of pathology and bacteriology, 55, 245-257.
Durrington P, Soran H. 2014. Hyperlipidemia. In: Metabolism of Human Diseases. Vienna. Springer, 295-302.
Eckel RH, Grundy SM. Zimmet PZ. 2005. The metabolic syndrome. The lancet, 365, 1415-1428.
Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, Smith RJ, Smith SR. 2011. Obesity and type 2 diabetes: What can be unified and what needs to be individualized. Diabetes Care, 34, 1424-1430.
Edholm T, Degerblad M, Grybäck P, Hilsted L, Holst JJ, Jacobsson H, Efendic S, Schmidt PT, Hellström PM. 2010. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin‐glucose homeostasis. Neurogastroenterology and Motility, 22, 1191-1201.
Erickson RH, Zakim D, Vessey DA. 1978. Preparation and properties of a phospholipid-free form of microsomal UDP-glucuronyltransferase. Biochemistry, 17, 3706-3711.
Erlanson-Albertsson C. 2002. Uncoupling preteins-a new family of proteins with unknown function. Nutritional neuroscience, 5, 1-11.
Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W, Desvergne B. 2001. Rat ppars: Quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology, 142, 4195-4202.
Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. 2004. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology, 145, 2273-2282.
Farmer SR. 2005. Regulation of PPARγ activity during adipogenesis. International journal of obesity, 29, 13-16.
Fernandez ML. 2001. Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Current opinion in lipidology, 12, 35-40.
Festa A, Williams K, Tracy RP, Wagenknecht LE., Haffner SM. 2006. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes. Circulation, 113, 1753-1759.
Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati PM. 2011. National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. The Lancet, 377, 557-567.
Fischer LJ. 1985. Drug and chemicals that produce diabetes. Journal of pharmacological sciences, 6, 72-75.
Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D, Warden CH. 1997. Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia. Nature genetics, 15, 269-272.
Folch J, Lees M, Solane GM. 1957. A simple method for the isolation and purification of total lipids from animal tissues. The journal of biological chemistry, 226, 497-509.
Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. 2007. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes, 56, 1010-1013.
Frias ACD, Sgarbieri VC. 1998. Guar gum effects on food intake, blood serum lipids and glucose levels of Wistar rats. Plant Foods for Human Nutrition, 53, 15-28.
Fruebis J, Tsao T, Javorschi S, Ebbets-Reed D, Erickson M, Yen F, Bihain B, Lodish, H. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proceedings of the national academy of sciences, 98, 2005-2010.
Fu YW., Hou WY, Yeh ST, Li CH, Chen JC. 2007. The immunostimulatory effects of hot-water extract of Gelidium amansii via immersion, injection and dietary administrations on white shrimp Litopenaeus vannamei and its resistance against Vibrio alginolyticus. Fish and shellfish immunology, 22, 673-685.
Fungwe TV, Cagen L, Wilcox HG, Heimberg M. 1992. Regulation of hepatic secretion of very low density lipoprotein by dietary cholesterol. Journal of lipid research, 33, 179-191.
Gaidhu MP, Anthony NM, Patel P, Hawke TJ, Ceddia RB. 2010. Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK. American Journal of Physiology-Cell Physiology, 298, 961-971.
Galisteo M, Morón R, Rivera L, Romero R, Anguera A, Zarzuelo A. 2010. Plantago ovata husks-supplemented diet ameliorates metabolic alterations in obese Zucker rats through activation of AMP-activated protein kinase. Comparative study with other dietary fibers. Clinical Nutrition, 29, 261-267.
Garcia-Diez F, Garcia-Mediavilla V, Bayon JE, Gonzalez-Gallego J. 1996. Pectin feeding influences fecal bile acid excretion, hepatic bile acid and cholesterol synthesis and serum cholesterol in rats. The journal of nutrition, 126, 1766-1771.
Gimeno RE, Dembski M, Weng X, Deng N, Shyjan AW, Gimeno CJ, Iris F, Ellis SJ, Woolf EA, Tartaglia LA. 1997. Cloning and characterization of an uncoupling protein homolog. Diabetes, 46, 900-906.
Ginsberg HN. 2000. Insulin resistance and cardiovascular disease. The journal of clinical investigation, 106, 453-458.
Ginzberg A, Cohen M, Sod-Moriah UA, Shany S, Rosenshtrauch A, Arad SM. 2000. Chickens fed with biomass of the red microalga Porphyridium sp. have reduced blood cholesterol level and modified fatty acid composition in egg yolk. Journal of Applied Phycology, 12, 325-330.
Goodridge AG. 1972. Regulation of the activity of acetyl coenzyme A carboxylase by palmitoyl coenzyme A and citrate. The journal of biological chemistry, 247, 6946-6952.
Gottlieb PA, Rossini AA, VI ADPBR. 2014. The BB rat models of IDDM. Autoimmune Disease Models, 163-174.
Gotto AM. 2002. Lipid management in diabetic patients: Lessons from prevention trials. American journal of medicine, 112, 19-26.
Greenberg AS, Kraemer FB, Soni KG, Jedrychowski MP, Yan QW, Graham CE, Bowman TA, Mansur A. 2011. Lipid droplet meets a mitochondrial protein to regulate adipocyte lipolysis. The European molecular biology organization journal, 30, 4337-4339.
Grover GJ, Koetzner L, Wicks J, Gahler RJ, Lyon MR, Reimer RA, Wood S. 2011. Effects of the soluble fiber complex PolyGlycopleX® (PGX®) on glycemic control, insulin secretion, and GLP-1 levels in Zucker diabetic rats. Life sciences, 88, 392-399.
Guilherme A, Virbasius, JV, Puri V, Czech MP. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature reviews molecular cell biology, 9, 367-377.
Gunness P, Gidley MJ. 2010. Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides. Food and function, 1, 149-155.
Guo F, Huang C, Liao X, Wang Y, He Y, Feng R, Li Y, Sun C. 2011. Beneficial effects of mangiferin on hyperlipidemia in high‐fat‐fed hamsters. Molecular nutrition and food research, 55, 1809-1818.
Guo P, Kai Q, Gao J, Lian ZQ, Wu CM, Wu CA, Zhu HB. 2010. Cordycepin prevents hyperlipidemia in hamsters fed a high-fat diet via activation of AMP-activated protein kinase. Journal of pharmacological sciences, 113, 395-403.
Haemmerle G, Zimmermann R, Hayn M, Theussl C, Waeg G, Wagner E, Sattler W, Magin TM, Wagner EF, Zechner R. 2002. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. Journal of Biological Chemistry, 277, 4806-4815.
Harada H, NORo T, Kamei Y. 1997. Selective antitumor activity in vitro from marine algae from Japan coasts. Biological and pharmaceutical bulletin, 20, 541-546.
Hardie DG, Scott JW, Pan DA, Hudson ER. 2003. Management of cellular energy by the AMP-activated protein kinase system. FEBS letters, 546, 113-120.
Hardie DG. 2007. AMP-activated protein kinase as a drug target. Annual review of pharmacology and toxicology, 47, 185-210.
Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, Rao MS. 2000. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. Journal of biological chemistry, 275, 28918-28928.
Heck AM, Yanovski JA, Calis KA. 2000. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy, 20, 270-279.
Holm C. 2003. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochemical society transactions, 31, 1120-1124.
Horton JD, Goldstein JL, Brown MS. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. Journal of clinical investigation, 109, 1125-1132.
Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science, 271, 665-668.
Howard BV, Lee ET, Cowan LD, Fabsitz RR, Howard WJ, Oopik AJ, Robbins DC, Savage PJ, Yeh JL, Welty TK. 1995. Coronary heart disease prevalence and its relation to risk factors in american indians. the strong heart study. American journal of epidemiology, 142, 254-268.
Hsieh YL, Yao HT, Cheng RS, Chiang MT. 2012. Chitosan reduces plasma adipocytokines and lipid accumulation in liver and adipose tissues and ameliorates insulin resistance in diabetic rats. Journal of medicinal food, 15, 453-460.
Hsu CL, Wu CH, Huang SL, Yen GC. 2009. Phenolic compounds rutin and o-coumaric acid ameliorate obesity induced by high-fat diet in rats. Journal of Agricultural and Food Chemistry, 57, 425-431.
Hu X, Li Y, Li C, Fu Y, Cai F, Chen Q, Li D. 2012. Combination of fucoxanthin and conjugated linoleic acid attenuates body weight gain and improves lipid metabolism in high-fat diet-induced obese rats. Archives of biochemistry and biophysics, 519, 59-65.
Huang SF. 1999. Floristic studies on the benthic marine algae of northeastern Taiwan. Taiwania, 44, 271-298.
Ide T, Moriuchi H, Nihimoto K. 1991. Hypolipidemic effects of guar gum and its enzyme hydrolysate in rats fed highly saturated fat diets. Annals of nutrition and metabolism, 35, 34-44.
Izem L, Morton RE. 2009. Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia. Journal of lipid research, 50, 676-684.
Jakobsdottir G, Xu J, Molin G, Ahrne S, Nyman M. 2013. High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PloS one, 8, 1-11.
Jang WS, Choung SY. 2013. Antiobesity effects of the ethanol extract of Laminaria japonica Areshoung in high-fat-diet-induced obese rat. Evidence-based complementary and alternative medicine, 2013, 1-18.
Jenkins DJ, Kendall CW, Vuksan V, Vidgen E, Parker T, Faulkner D, Mehling CC, Garsetti M, Testolin G, Cunnane SC, Ryan MA, Corey PN. 2002. Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: Serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. The American journal of clinical nutrition, 75, 834-839.
Jeong GT, Park DH. 2010. Production of sugars and levulinic acid from marine biomass Gelidium amansii. Applied biochemistry and biotechnology, 161, 41-52.
Jiménez-Escrig A, Sánchez-Muniz FJ. 2000. Dietary fibre from edible seaweeds: chemical structure, physicochemical properties and effects on cholesterol metabolism. Nutrition Research, 20, 585-598.
Kadowaki T, Yamauchi T. 2005. Adiponectin and adiponectin receptors. Endocrine reviews, 26, 439-451.
Kamalakkannan N, Prince PSM. 2006. Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues. Molecular and cellular biochemistry, 293, 211-219.
Kang ES, Park SY, Kim HJ, Ahn CW, Nam M, Cha BS, Lee HC. 2005. The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes. Diabetes Care, 28, 1139-1144.
Kang JH, Lee HA, Kim HJ, Han JS. 2017. Gelidium amansii extract ameliorates obesity by down-regulating adipogenic transcription factors in diet-induced obese mice. Nutrition research and practice, 11, 17-24.
Kang MC, Kang N, Kim SY, Lima IS, Ko SC, Kim YT, Kim YB, Jeung HD, Choi K S, Jeon YJ. 2016. Popular edible seaweed, Gelidium amansii prevents against diet-induced obesity. Food and chemical toxicology, 90, 181-187.
Karhapää P, Malkki M, Laakso M. 1994. Isolated low HDL cholesterol. An insulin-resistant state. Diabetes, 43, 411-417.
Kasuga M. 2006. Insulin resistance and pancreatic beta cell failure. Journal of clinical investigation, 116, 1756-1760.
Kaur J. 2014. A comprehensive review on metabolic syndrome. Cardiology research and practice, 2014, 1-21.
Kelly LJ, Vicario PP, Thompson GM, Candelore MR, Doebber TW, Ventre J, Wu MS, Meurer R, Forrest MJ, Conner MW, Cascieri MA, Cascieri MA. 1998. Peroxisome proliferator-activated receptors γ and α mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology, 139, 4920-4927.
Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. 2001. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American journal of physiology-endocrinology and metabolism, 280, 745-751.
Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. 2004. The journal of clinical endocrinology and metabolism, 89, 2548-2556.
Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. 1999. Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting. The Journal of clinical investigation, 103, 1489-1498.
Kim C, Newton KM, Knopp RH. 2002. Gestational diabetes and the incidence of type 2 diabetes a systematic review. Diabetes care, 25, 1862-1868.
Kim MS, Kim JY, Choi WH, Lee SS. 2008. Effects of seaweed supplementation on blood glucose concentration, lipid profile, and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Nutrition research and practice, 2, 62-67.
Kishimoto Y, Yoshikawa Y, Miyazato S, Oga H, Yamada T, Tagami H, Hashizume C, Yamamoto K. 2009. Effect of resistant maltodextrin on digestion and absorption of lipids. Journal of health science, 55, 838-844.
Kota BP, Huang THW, Roufogalis BD. 2005. An overview on biological mechanisms of PPARs. Pharmacological research, 51, 85-94.
Kowala MC, Nunnari JJ, Durham SK, Nicolosi RJ. 1991. Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters. Atherosclerosis, 91, 35-49.
Kruszynska YT, Yu JG, Olefsky JM, Sobel BE. 2000. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes, 49, 633-639.
Kuem N, Song SJ, Yu R, Yun JW, Park T. 2014. Oleuropein attenuates visceral adiposity in high‐fat diet‐induced obese mice through the modulation of WNT10b‐and galanin‐mediated signalings. Molecular nutrition and food research, 58, 2166-2176.
Kusunoki M, Hara T, Tsutsumi K, Nakamura T, Miyata T, Sakakibara F, Sakamoto S, Ogawa H, Nakaya Y, Storlien LH. 2000. The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet. Diabetologia, 43, 875-880.
Labropoulos KC, Niesz DE, Danforth SC, Kevrekidis PG. 2002. Dynamic rheology of agar gels: theory and experiments. Part I. Development of a rheological model. Carbohydrate polymers, 50, 393-406.
Lanni A, Moreno M, Lombardi A, Goglia F. 2003. Thyroid hormone and uncoupling proteins. FEBS letters, 543, 5-10.
Lee HJ, Kim HC, Vitek L, Nam CM. 2009. Algae consumption and risk of type 2 diabetes: Korean National Health and Nutrition Examination Survey in 2005. Journal of nutritional science and vitaminology, 56, 13-18.
Lee JW, Choe SS, Jang H, Kim J, Jeong HW, Jo H, Tadi S, Park MG, Kwak TH, Kim JM, Hyum DH, Kim JB. 2012. AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity. Journal of lipid research, 53, 1277-1286.
Lee MS, Kim KJ, Kim D, Lee KE, Hwang JK. 2011a. Meso-Dihydroguaiaretic acid inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in human HepG2 cells. Biological and pharmaceutical bulletin, 34, 1628-1630.
Lee SJ, Kim CW, Jang HJ, Cho SY, Choi JW. 2011b. Anti-hyperlipidemia and anti-arteriosclerosis effects of Laminaria japonica in sprague-dawley rats. Fisheries and aquatic sciences, 14, 235-241.
Lehrke M, Lazar MA. 2005. The many faces of PPARγ. Cell, 123, 993-999.
LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, Yakar S. 2008. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Experimental and clinical endocrinology and diabetes, 116, 4-6.
Lewis JE, Norris JN. 1987. A history and annotated account of the benthic marine algae of Taiwan. Smithsonian contributions to the marina sciences, 29, 1-48.
Li W, Li Y, Wang Q, Yang Y. 2014. Crude extracts from Lycium barbarum suppress SREBP-1c expression and prevent diet-induced fatty liver through AMPK activation. BioMed research international, 2014, 1-10.
Li X, Kimura H, Hirota K, Kasuno K, Torii K, Okada T, Kurooka H, Yokota Y, Yoshida H. 2005. Synergistic effect of hypoxia and TNF-α on production of PAI-1 in human proximal renal tubular cells. Kidney international, 68, 569-583.
Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Gao B, Park O, Luo Z, Lefai E, Shyy JYJ, Gao B, Wierzbicki M, Verbeuren TJ, Shaw RJ, Cohen RA, Zang M. 2011. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell metabolism, 13, 376-388.
Liao CC, Ou TT, Wu CH, Wang CJ. 2013. Prevention of diet-induced hyperlipidemia and obesity by caffeic acid in C57BL/6 mice through regulation of hepatic lipogenesis gene expression. Journal of agricultural and food chemistry, 61, 11082-11088.
Lin MH, Lu SC, Huang PC, Liu YC, Liu SY. 2004. The amount of dietary cholesterol changes the mode of effects of (n-3) polyunsaturated fatty acid on lipoprotein cholesterol in hamsters. Annals of nutrition and metabolism, 48, 321-328.
Liu SH, He SP, Chiang MT. 2012. Effects of long-term feeding of chitosan on postprandial lipid responses and lipid metabolism in a high-sucrose-diet-impaired glucose-tolerant rat model. Journal of agricultural and food chemistry, 60, 4306-4313.
Lottenberg SA, Glezer A, Turatti LA. 2007. Metabolic syndrome: Identifying the risk factors. Jornal de pediatria, 83, 204-208.
Maeda H, Hosokawa M, Sashima T, Murakami-Funayama K, Miyashita K. 2009. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Molecular medicine reports, 2, 897-902.
Maeda H, Yamamoto R, Hirao K, Tochikubo O. 2005. Effects of agar (kanten) diet on obese patients with impaired glucose tolerance and type 2 diabetes. Diabetes, obesity and metabolism, 7, 40-46.
Martinez-Flores HE, Chang YK, Martinez-Bustos F, Sgarbieri V. 2004. Effect of high fiber products on blood lipids and lipoproteins in hamsters. Nutrition research, 24, 85-93.
Mashige F, Tanaka N, Maki A, Kamei S, Yamanaka M. 1981. Direct spectrophotometry of total bile acids in serum. Clinical chemistry, 27, 1352-1356.
Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D. 1998. Experimental niddm: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes, 47, 224-229.
Matsuzawa Y, Funahashi T, Nakamura T. 1999. Molecular mechanism of metabolic syndrome x: contribution of adipocyte-derived bioactive substances. Annals of the new york academy of sciences, 892, 146-154.
Matthews DR, Hosker JR, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
Miller GL. 1959. Use of dinitrosalicylic acid reagent for determination of reducing sugar. Analytical chemistry, 31, 426-428.
Minekus M, Jelier M, Xiao JZ, Kondo S, Iwatsuki K, Kokubo S, Iwatsuki K, Kokubo S, Bos M, Dunnewind B, Havenaar R. 2005. Effect of partially hydrolyzed guar gum (PHGG) on the bioaccessibility of fat and cholesterol. Bioscience biotechnology and biochemistry, 69, 932-938.
Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yud- kin JS, Klein S, Coppack SW. 1997. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo 1. The journal of clinical endocrinology and metabolism, 82, 4196-4200.
Moller DE. 2000. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends in endocrinology and metabolism, 11, 212-217.
Moro CO, Basile G. 2000. Obesity and medicinal plants. Fitoterapia, 71, 73-82.
Motta M, Bennati E, Ferlito L, Malaguarnera M. 2006. Diabetes mellitus in the elderly: Diagnostic features. Archives of gerontology and geriatrics, 42, 101-106.
Müller G, Ertl J, Gerl M, Preibisch G. 1997. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. The journal of biological chemistry, 272, 10585-10593.
Nakamura T, Terajima T, Ogata T, Ueno K, Hashimoto N, Ono K, Yano S. 2006. Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide. Biological and Pharmaceutical Bulletin, 29, 1167-1174.
Nakamura Y, Kanazawa M, Liyanage R, Iijima S, Han KH, Shimada KI, Sekikawa M, Yamauchi A, Hashimoto N, Ohba K, Fukushima M. 2009. Effect of white wheat bread containing sugar beet fiber on serum lipids and hepatic mRNA in rats fed on a cholesterol-free diet. Bioscience, biotechnology, and biochemistry, 73, 1280-1285.
Nakatani T, Tsuboyama-Kasaoka N, Takahashi M, Miura S, Ezaki O. 2002. Mechanism for peroxisome proliferator-activated receptor-α activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes. Journal of biological chemistry, 277, 9562-9569.
Nelson RH. 2013. Hyperlipidemia as a risk factor for cardiovascular disease. Primary care: Clinics in office practice, 40, 195-211.
Ni HC, Li J, Jin Y, Zang HM, Peng L. 2004. The experimental animal model of hyperlipidemia and hyperlipidemic fatty liver in rats. Chinese pharmacological bulletin, 20, 703-706.
Nieto MB. 2009. Structure and function of polysaccharide gum-based edible films and coatings. In: Edible films and coatings for food applications. New York. Springer, 61-62.
Nonogaki K, Fuller GM, Fuentes NL, Moser AH, Staprans I, Grunfeld C, Feingold K. R. 1995. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology, 136, 2143-2149.
Numa S, Ringelmann E, Lynen F. 1965. On inhibition of acetyl-CoA-carboxylase by fatty acid-coenzyme A compounds. Biochemische Zeitschrift, 343, 243-257.
Nussinovitch A. 1997. Agar. In: hydrocolloid applications. Boston. Springer, 1-18.
Okuda H, Morimoto C, Tsujita T. 1994. Effect of substrates on the cyclic AMP-dependent lipolytic reaction of hormone-sensitive lipase. Journal of lipid research, 35, 1267-1273.
Ong JM, Kern PA. 1989. Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue. Journal of clinical investigation, 84, 305-311.
Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. 1999. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 100, 2473-2476.
Panahloo A, Yudkin JS. 1997. Diminished fibrinolysis in diabetes mellitus and its implications for diabetic vascular disease. Journal of cardiovascular risk, 4, 91-99.
Park EY, Kim EH, Kim MH, Seo YW, Lee JI, Jun HS. 2012. Polyphenol-rich fraction of brown alga Ecklonia cava collected from Gijang, Korea, reduces obesity and glucose levels in high-fat diet-induced obese mice. Evidence-based complementary and alternative medicine, 2012, 1-11.
Paton CM, Ntambi JM. 2009. Biochemical and physiological function of stearoyl-CoA desaturase. American journal of physiology-endocrinology and metabolism, 297, 28-37.
Peixoto MDRG, Benício MHDA, Latorre MDRDD, Jardim PCBV. 2006. Waist circumference and body mass index as predictors of hypertension. Arquivos brasileiros de cardiologia, 87, 462-470.
Pengzhan Y, Quanbin Z, Ning L, Zuhong X, Yanmei W, Zhi'en L. 2003. Polysaccharides from Ulva pertusa (Chlorophyta) and preliminary studies on their antihyperlipidemia activity. Journal of applied phycology, 15, 21-27.
Pittas AG, Joseph NA, Greenberg AS. 2004. Adipocytokines and insulin resistance. The journal of clinical endocrinology and metabolism, 89, 447-452.
Qi H, Li D, Zhang J, Liu L, Zhang Q. 2008. Study on extraction of agaropectin from Gelidium amansii and its anticoagulant activity. Chinese journal of oceanology and limnology, 26, 186-189.
Quintao ECR, Sperotto G. 1987. The role of dietary cholesterol in the regulation of human body cholesterol metabolism. Advances in lipid research, 22, 173-188.
Reaven GM. 1988. Role of insulin resistance in human disease. Diabetes, 37, 1595-1607.
Reaven GM. 2002. Multiple CHD risk factors in type 2 diabetes: Beyond hyperglycaemia. Diabetes, obesity and metabolism, 4, 13-18.
Reaven GM. Pathophysiology of insulin resistance in human disease. 1995. Physiological reviews, 75, 473-486.
Rideout TC, Harding SV, Jones PJ, Fan MZ. 2008. Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: Current understandings and future research priorities. Vascular health and risk management, 4, 1023-1033.
Robertson RP. 2004. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. Journal of biological chemistry, 279, 42351-42354.
Rohner-Jeanrenaud F, Cusin I, Sainsbury A, Zakrzewska KE, Jeanrenaud B. 1996. The loop system between neuropeptide Y and leptin in normal and obese rodents. Hormone and metabolic research, 28, 642-648.
Rutter G, dasilvaxavier G, Leclerc I. 2003. Roles of 5-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochemical journal, 375, 1-16.
Sakai M. 1999. Current research status of fish immunostimulants. Aquaculture, 172, 63-92.
Saltiel AR, Kahn CR. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414, 799-806.
Samad F, Uysal KT, Wiesbrock SM, Pandey M, Hotamisligil GS, Loskutoff DJ. 1999. Tumor necrosis factor-α is a key component in the obesity-linked elevation of plasminogen activator-inhibitor 1. Proceedings of the national academy of sciences, 96, 6902-6907.
Samiey B, Ashoori F. 2012. Adsorptive removal of methylene blue by agar: effects of NaCl and ethanol. Chemistry central journal, 6, 1-14.
Sanderson LM, Boekschoten MV, Desvergne B, Müller M, Kersten S. 2010. Transcriptional profiling reveals divergent roles of PPARα and PPARβ/δ in regulation of gene expression in mouse liver. Physiological genomics, 41, 42-52.
Scarpace PJ, Matheny M, Zolotukhin S, Tumer N. Zhang Y. 2003. Leptin-induced leptin resistant rats exhibit enhanced responses to the melanocortin agonist mt II. Neuropharmacology, 45, 211-219.
Schneeman BO. 1999. Fiber, inulin and oligofructose: similarities and differences. The Journal of nutrition, 129, 1424-1427.
Schrauwen P, Hesselink M. 2002. UCP2 and UCP3 in muscle controlling body metabolism. The journal of experimental biology, 205, 2275-2285.
Semenkovich CF, Heinecke JW. 1997. The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes, 46, 327-334.
Senn JJ, Klover PJ, Nowak IA, Mooney RA. 2002. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes, 51, 3391-3399.
Seo MJ, Lee OH, Choi HS, Lee BY. 2012. Extract from edible red seaweed (Gelidium amansii) inhibits lipid accumulation and ros production during differentiation in 3T3-L1 cells. Preventive nutrition and food science, 17, 29-35.
Sessions VA, Salter AM. 1994. The effects of different dietary fats and cholesterol on serum lipoprotein concentrations in hamsters. Biochimica et biophysica acta -lipids and lipid metabolism, 1211, 207-214.
Setji TL, Brown AJ, Feinglos MN. 2005. Gestational diabetes mellitus. Clinical diabetes, 23, 17-24.
Shafrir E, Ziv E, Mosthaf L. 1999. Nutritionally induced insulin resistance and receptor defect leading to β‐cell failure in animal models. Annals of the New York academy of sciences, 892, 223-246.
Shakoor S, Kanwal A, Abbas N, Mirza MA, Arif S. 2014. Effect of natural dietary fibers (wheat porridge) on hyperlipidemia rats. Journal of global innovation in agricultural and social sciences, 2, 39-44.
Sharma PA, Deshpande SS, Shah GB. 2013. In-house validation of high fat diet induced obesity models. Biomedrx, 1, 51-58.
Shen L, Xiong Y, Wang DQ, Howles P, Basford JE, Wang J, Xiong YQ, Hui DY, Woods SC, Liu M. 2013. Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. Journal of lipid research, 54, 1430-1438.
Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M. 2007. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes care, 30, 2940-2944.
Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB. Unger RH. 1997. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proceedings of the national academy of sciences of the united states of america, 94, 4637-4641.
Shimomura I, Hammer RE, Richardson JA, Ikemoto S, Bashmakov Y, Goldstein JL, Brown MS. 1998. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes and development, 12, 3182-3194.
Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS. 1997. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. Journal of clinical investigation, 99, 838-845.
Siersbæk R, Nielsen R, Mandrup S. 2010. PPARγ in adipocyte differentiation and metabolism–novel insights from genome-wide studies. FEBS letters, 584, 3242-3249.
Singh T. 1992. Agar and agar production. Infofish, 7, 1-25
Srinivasan K, Ramarao P. 2007. Animal models in type 2 diabetes research: an overview. Indian journal of medical research, 125, 451-472.
Stoloff L, Silva P. 1957. An attempt to determine possible taxonomic significance of the properties of water extractable polysaccharides in red algae. Economic botany, 11, 327-330.
Sullivan MP, Cerda JJ, Robbins FL, Burgin CW, Beatty RJ. 1993. The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia. Laboratory animal science, 43, 575-578.
Sun J, Wang YJ, Zhu LY, Yang RY. 2007. Study on antifungal and antioxidant activities of alcohol extract of Gelidium amansii. Journal of food science, 28, 53-56.
Sung YY, Kim DS, Choi G, Kim SH, Kim HK. 2014. Dohaekseunggi-tang extract inhibits obesity, hyperlipidemia, and hypertension in high-fat diet-induced obese mice. BMC complementary and alternative medicine, 14, 372-380.
Surwit RS, Wang S, Petro AE, Sanchis D, Raimbault S, Ricguier D, Collins S. 1998. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proceedings of the national academy of sciences of the United States of America, 95, 4061-4065.
Suzuki T, Hara H. 2004. Ingestion of guar gum hydrolysate, a soluble and fermentable nondigestible saccharide, improves glucose intolerance and prevents hypertriglyceridemia in rats fed fructose. The Journal of nutrition, 134, 1942-1947.
Szkudelski T. 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiological research, 50, 537-546.
Tahara A, Matsuyama-Yokono A, Shibasaki M. 2011. Effects of antidiabetic drugs in high-fat diet and streptozotocin-nicotinamide-induced type 2 diabetic mice. European journal of pharmacology, 655, 108-116.
Takehisa F, Suzuki Y. 1990. Effect of guar gum and cholestyramine on plasma lipoprotein cholesterol in rats. Journal of Japanese society of nutrition and food science (Japan), 43, 269-274.
Talayero BG, Sacks FM. 2011. The role of triglyceride in atherosclerosis. Current cardiology reports, 13, 544-552.
Terho TT, Hartiala K. 1971. Method for determination of the sulfate content of glycosaminoglycans. Analytical biochemistry, 41, 471-476.
Tisdale MJ. 2005. Molecular pathways leading to cancer cachexia. Physiology, 20, 340-348.
Vaughan DE. 2005. PAI-1 and atherothrombosis. Journal of thrombosis and haemostasis, 3, 1879-1883.
Vázquez-Vela MEF, Torres N, Tovar AR. 2008. White adipose tissue as endocrine organ and its role in obesity. Archives of medical research, 39, 715-728.
Vitali A, Murano I, Zingaretti MC, Frontini A, Ricquier D, Cinti S. 2012. The adipose organ of obesity-prone C57BL/6J mice is composed of mixed white and brown adipocytes. Journal of lipid research, 53, 619-629.
Wakabayashi S, Satouchi M, Nogami Y, Ohkuma K, Matsuoka A. 1991. Effect of indigestible dextrin on cholesterol metabolism in rat. Journal of Japanese society of nutrition and food science (Japan), 44, 471-478.
Wakabayashi S. 1993. The effects of Indigestible dextrin on sugar tolerance: III. Improvement in sugar torelance by indigestible dextrin on the impaired glucose tolerance model. Folia endocrinol , 69, 594-608.
Wang H, Eckel RH. 2009. Lipoprotein lipase: From gene to obesity. American journal of physiology-endocrinology and metabolism, 297, 271-288.
Wang H, Zhou X, Tang F, Zuo SH. 2011a. An experimental study on the hypoglycemic effect of agar polysaccharide in diabetic rats. Health medicine research and practice, 4, 004.
Wang X, Hasegawa J, Kitamura Y, Wang Z, Matsuda A, Shinoda W, Miura N, Kimura K. 2011b. Effects of hesperidin on the progression of hypercholesterolemia and fatty liver induced by high-cholesterol diet in rats. Journal of pharmacological sciences, 117, 129-138.
Wang ZQ, Yu Y, Zhang XH, Floyd ZE, Boudreau A, Lian K, Cefalu WT. 2012. Comparing the effects of nano-sized sugarcane fiber with cellulose and psyllium on hepatic cellular signaling in mice. International journal of nanomedicine, 7, 2999-3012.
Wang ZQ, Zuberi AR, Zhang XH, Macgowan J, Qin J, Ye X, Son L, Wu Q, Lian K, Cefalu WT. 2007. Effects of dietary fibers on weight gain, carbohydrate metabolism, and gastric ghrelin gene expression in mice fed a high-fat diet. Metabolism, 56, 1635-1642.
Watt MJ, Carey AL, Wolsk-Petersen E, Kraemer FB, Klarland Pedersen B, Febbraio MA. 2005. Hormone-sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus: Influence of IL-6 infusion. Diabetologia, 48, 105-112.
Watt MJ, Holmes AG, Pinnamaneni SK, Garnham AP, Steinberg GR, Kemp BE, Febbraio MA. 2006. Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. American journal of physiology-endocrinology and metabolism, 290, 500-508.
Watts GF, Karpe F. 2011. Triglycerides and atherogenic dyslipidaemia: Extending treatment beyond statins in the high risk cardiovascular patient. Heart, 97, 350-356.
Weitkunat K, Schumann S, Nickel D, Kappo KA, Petzke KJ, Kipp A. P, Klaus S. 2016. Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high‐fat diet induced obesity. Molecular nutrition and food research, 60, 2611-2621.
Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. The journal of clinical endocrinology and metabolism, 86, 1930-1935.
World Health Organization. 2009. Health topics, diabetes, fact sheet: diabetes. Retrieved December 1, 2009 from http://www.who.int/mediacentre/factsheets/fs312/en/
World Health Organization. 2011. Health topics, diabetes, fact sheet: diabetes. Retrieved October 21, 2011 from http://www.who.int/mediacentre/factsheets/fs312/en/
Yamauchi T, Kamon J, Minokoshi YA, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre O, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature medicine, 8, 1288-1295.
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama N. 2001. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature medicine, 7, 941-946.
Yang TH, Yao HT, Chiang MT. 2015. Red algae (Gelidium amansii) reduces adiposity via activation of lipolysis in rats with diabetes induced by streptozotocin-nicotinamide. Journal of food and drug analysis, 23, 758-765.
Yang TH, Yao HT, Chiang MT. 2017. Red algae (Gelidium amansii) hot-water extract ameliorates lipid metabolism in hamsters fed a high-fat diet. Journal of Food and drug analysis, 1-8.
Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB. 2006. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator–activated receptor α. Diabetes, 55, 2562-2570.
Yoshioka H, Tsuyumu S, Takayanagi K. 1990. Radical formation during the processing of green tea. Agricultural and Biological Chemistry, 54, 203-204.
Yuasa N, Yasue M, Ikeda M, Shinoda Y, Sato K, Kondo A. 2004. The effects of tea beverage containing indigestible dextrin on postprandial blood glucose level after single intake and the safety in continuous intakes. Journal of Japan council for advanced food ingredients research, 7, 83-93.
Yumiko YS, Ya-Pei H, Takeshi S. 2003. Distribution of flavonoids and related compounds from seaweeds in Japan. Journal-Tokyo University of Fisheries, 89, 1-6.
Yun H, Lee JH, Park CE, Kim MJ, Min BI, Bae H, Choe W, Kang I, Kim SS, Ha J. 2009. Inulin increases glucose transport in C2C12 myotubes and HepG2 cells via activation of AMP-activated protein kinase and phosphatidylinositol 3-kinase pathways. Journal of medicinal food, 12, 1023-1028.
Zander M, Madsbad S, Madsen JL, Holst JJ. 2002. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: A parallel-group study. The lancet, 395, 824-830.
Zhang Z, Wang H, Jiao R, Peng C, Wong YM, Yeung VS, Huang Y, Chen ZY. 2009. Choosing hamsters but not rats as a model for studying plasma cholesterol‐lowering activity of functional foods. Molecular nutrition and food research, 53, 921-930.
Zhu FS, Liu S, Chen XM, Huang ZG, Zhang DW. 2008. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World journal of gastroenterology, 14, 6395-6400.
Zou ZY, Hu YR, Ma H, Wang YZ, He K, Xia S, Wu H, Xue DF, Li XG, Ye XL. 2015. Coptisine attenuates obesity-related inflammation through LPS/TLR-4-mediated signaling pathway in syrian golden hamsters. Fitoterapia, 105, 139-146.